/
CMPS
$13.29-$0.93 (-6.54%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$2.0B
138M shares
52-week range
$3.97 – $15.40
82% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
ADRC
Change$-16.72
COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
compasspathways.com- Employees
- 156
- IPO / List date
- Sep 18, 2020
- HQ
- CHESIRE, X0
Held by traders on TradeandTell
No one on the platform currently holds CMPS.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 865,354 | $4.8M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded CMPS yet.
